Infants with congenital hypothyroidism (CHI have a n o m l size at birth.Gravth during the f i r s t weeks of l i f e has not yet been studied although CH offers a mdel t o describe the effect of thyroid homne on grcwth during early infancy. Thyroid scan and thyrcglobulin determination were perfonred i n 47 infants with CH a l l m i n g classification into the f o l l m i n g groups: athyreosis n. 13, ectopic n=25 and eutopic gland n=9. Infants were wasured at birth, at diagnosis (less than 1 m n t h of age) and 2, 4, 8 weeks after therapy. Height was expressed i n standard clsviation score and corl-ccted f o r gestational age according t o i n t r a and extrauterine grcwth standards of Largo e t al. Bone age was retarded at b i r t h and at diagnosis, epiphyseal surfaces of the knee were correlated with plasma T4 values. By contrast, height (wan t 9 ) at b i r t h was n o m l (0.3 f 0.8 53) with identical distribution m g the 3 subgroups. At diagnosis it was at -0.1 + 0.6 9, a value significantly different fran the value at b i r t h (~(0.05). After 2 wedts of therapy a continuous decline i n grcwth v i l c c i t y was observed, reaching -0.2 * 0.7 SD at 6 w k s cf l i f e (p<0.02 vs size at birth). Grcwth retardation was correlated with the illtensity of thyroid deficiency. Mean height after 2 weeks of therapy was a t -0.6, -0.1, 0.1 SD i n patients with respectively athyreosis, ectopic and eutopic gland. Catch-up grcwth was observed thereafter, height reaching 0.3 SD at 12 weeks f o r the entire group. I n conclusion: A significant decreased height velocity was observed i n CH befEFfEF@Gnd was m r e pronounced i n severe hypothyroidism. I n contrast t o fetal period, thyroid honmne play an inportant role on grmth during early weeks of l i f e . This systen i s operating imrPdiatly after birth. 
t i n g newborns w i t h Ckl f r o m t h o s e w i t h t r a n s i e n t h y p e r t h y r o t r o p i n a e m i a (TH) . &-FP was measured b y a RIA method. We s t u d i e d 60 newborns w i t h CH and 184 newborns w i t h TH.
The mean g e s t a t i o n a l age (GA) o f CH group was 39,9?1,5 weeks (meaniSD) and o f TH group 39,2-11,9 w e e k s . 0 i s c r i m i n a n t ana-! y s i s was used a f t e r l o g a r i t h m i c t r a n s f o r~r~a t i o n o f 13-FP values, i n o r d e r t o f i n d t h e l i n e a r combination o f a -F P a n d GA, w h i c h bc-st d i s c r i m i n a t e s between Cti and TH cases. The meatlLS0 o f q-FP i n CH group was 32,6~31,1pg/ml, whereas t h e correspondinq f i g u r e f o r TH group was 13,8i16,0vg/1nl, d i f f e r e n c e s t a t i s t i c a l l y s i g n i f i c a n t (p <0,001). The d i s c r i n i i n a n t f u n c t i o n o f l o g Q-TI) and GA *las 35,57(1ogd-FP)+4,89(GA)-341,91.
T h i s e q u a t i o n c l a s s i f i e s a case t o t h e CH group i f i t has a p o s i t i v e v a l u e and t o t h e TI! group
o t h e r w i s e . The m i s c l a s s i f i c a t i o n r a t e i s about 26%. I n c o n c l h s i o n a -F P values i n d r i e d b l o o d spots a r e s i g n i f i c a n t l y I l i a h e r i n CH newborns t h a n i n TH ones and t h e n:easurenient o f a-FP i n CH 8crec.ni n g progralnnles c o u l d o f f e r a d i a g n o s t i c a i d i n d i f f e r e n t i i t i n g Ctl from Tti newborns, e s p e c i a l l y those wi-tl, L o r d e r l i n e TSH v a l u e s .
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GONADOTROPHIN, GROWTH HORMONE AND PROLACTIN SECRETORY DYSFUNCTION IN PRIMARY HYPOTHYROIDISM.
We have s t u d i e d 5 p r e p u b e r t a l g i r l s (age 6.7 -12.3 y r ) and 2 boys (age 13.3 and 14.2 y r ) i n e a r l y p u b e r t y ( s t a g e 2 g e n i t a l i a ) w i t h p r i m a r y h y p o t h y r o i d i s m . O v e r n i g h t serum hormone p r o f i l e s (15-minute sampling) were performed a t d i a g n o s i s and a f t e r 3 and 6 months o f replacement t h e r a p y ( T h y r o x i n e 100pg/m2/day). Pre-treatment, t h e g i r l s had peak TSH l e v e l s 850-4800 mU/1 w i t h FSH c o n c e n t r a t i o n s r a i s e d (peak 3.9-19.5 U / l ) above t h e LH l e v e l s (peak 1.8-3.7 U / l ) which were non-pul s a t i l e . P e l v i c u l t r asound showed small nu~nbers o f o v a r i a n c y s t s w i t h o u t a m u l t i c y s t i c morphology. P r o l a c t i n c o n c e n t r a t i o n s were e l e v a t e d and p u l s a t i l e (peaks 800-4600 mU/l). P r o g r e s s i v e f a l l s i n TSH, p r o l a c t i n and FSH o c c u r r e d d u r i n g t r e a t m e n t . LH l e v e l s were unchanged i n 3 g i r l s b u t increased, becoming p u l s a t i l e i n t h e 2 o l d e r g i r l s , who a l s o progressed t o b r e a s t stage 2 by 3 months. GH p u l s e a m p l i t u d e i n c r e a s e d d u r i n g t r e a t m e n t .
I n c o n t r a s t , t h e boys had l e s s severe hypothyroidism. Pret r e a t m e n t TSH l e v e l s were 210 and 1400 mU/1 ; p r o l a c t i n l e v e l s were e l e v a t e d t o 1200 and 1700 mU/1. Gonadotrophin p r o f i l e s showed p u l s a t i l e p a t t e r n s a p p r o p r i a t e f o r e a r l y p u b e r t y w i t h LH p r e d o m i n a t i n g o v e r FSH.
Raised FSH s e c r e t i o n occurs as a spectrum i n c h i l d r e n w i t h p r i m a r y hypothyrodism, even i n those w i t h o u t abnormal sexual development. and with minor neuromotor disorders including hyporeflexla (21.2),hyperrcflexia/clonus of the rotula and or foot (30%),dyslalia (G.l%).These findings could be considered as minor manifestations of neurological endemic cretinism. It must be noted that these defects are not only the clue of that severe endemla since the extensio~~ of iile study iu another community of 119 schoolchildren livlng in an area with a goiter prevalence of 59% revealed a 12.6% children with comparable mental and neuromotor defects.Despite an actual sharp decrease in goiter prevalence in both areas (79-44%
, 59-26%),these lodine deficiency disorders seem to persist hitherto.If neurological damage 1s due to iodine deficiency "per se" or to maternal hypothyroxinemia is st111 unclear.
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SERUM TIIYROXINE (T4) AN0 THYROTROPIIIN STIMULATING HORNONC (TSH) LEVELS IN CHILDREN TREATED FOR CONGCNITN HYPOTHYROIDISM
Between 1981 and 1985 105,723 infants (99.71 of newborn population) born in the South West of England usre screered for congi?nital hypothyroidism using an immunorediometric assay for TSH.42 inrants (16 boys and 26 girls) were diagnosed as having primary congenital hypothyroidism (incidence 1:440O).Treatment and progress were monitored by local paediatricians.
Following therapy TSH remained elevated in 52: of infants at3 months, 33% at 12 months, 24% between 2-3 years and in one a t 4 years.Serum 74 was newer below the normal range for age throughout the study period but uas significantly higher in those children who had normal TSH levels. 152 128 There was a wide range of L-thyroxine dosage at all age groups and it was those with the lower doses per Kg body weight who had the raised TSH 1evels.The clinical characteristics of the group were similar with satisfactory growth and deuslopment in all children.
We concludc that a significant number of chilSren treated for congenital hypothyroidism I i a v c raised T S l i lrivcls in association with T4 levels in the reported nornal range during the first 4 years of life.Pos5ible reasons for this will be discuss~d. SUE children had subtle t e k i v i w a l signs of over-treatmt i n i t i a l l y ; i n mw was bone age advanced.
Wan values for T3, T4, Free T3 t Free T4 a l l f e l l a t the u p p~ l i n i t of the ml range cn both i n i t i a l an3 cptiral dosaq?.
We cmlucie that c m n t dosage recarnerdations fcr L. Thyoxire m y k I m high an3 highly sensitive T.S.H. assay assist i n t i t r a t i o n of dosage.
